Clinical updates, including trial initiations, enrollment status and data readouts and publications: Briacell, Cohbar, Cyxone, Escient, Kineta, Madrigal, Sirnaomics.
Nanodx Inc. entered into a license agreement with IBM Research to use IBM’s nanoscale sensor technology and develop diagnostic platforms for rapid and cost-effective detection of various diseases, including COVID-19 and traumatic brain injury, among others. This marks IBM’s first collaboration to allow a medical device company to use its nanoscale technology.
Clinical updates, including trial initiations, enrollment status and data readouts and publications: Atheart Medical, Curebase, Exagen, Inbios, Intuitap Medical, Medical Microinstruments, Pear Therapeutics, Spinex, Vessi Medical.
The lack of data surrounding the efficacy of Chinese COVID-19 vaccines against the Delta variant has had many questioning them, especially after a recent study showed that one of those vaccines, Sinovac Biotech Ltd.’s Coronavac, was less effective than Pfizer Inc. and Biontech SE’s Comirnaty in Chile.
Hoping to get Germany to drop its opposition to a proposed World Trade Organization (WTO) waiver of intellectual property (IP) rights, several U.S. lawmakers have asked to meet with German Chancellor Angela Merkel when she’s in Washington for a July 15 summit with President Joe Biden.
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Akeso, Arca, Artax, AVM, Evgen, Innovent, Moleculin, Oryzon, Targovax, Valo.
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Abcam, Bicycle, Hoth, Hutchmed, Ionis, M8, Palisade Bio, Pionyr, RDIF, UCB.
Sonde Health struck a deal with Qualcomm Technologies Inc. to embed its vocal health biomarker product, Sonde One, in the Snapdragon 888 and 778G 5G mobile platforms. The deal would make vocal biomarker monitoring native to the devices that use the company’s chips in mobile and IoT devices.
RSS
